These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11416111)

  • 1. Reovirus as an oncolytic agent against experimental human malignant gliomas.
    Wilcox ME; Yang W; Senger D; Rewcastle NB; Morris DG; Brasher PM; Shi ZQ; Johnston RN; Nishikawa S; Lee PW; Forsyth PA
    J Natl Cancer Inst; 2001 Jun; 93(12):903-12. PubMed ID: 11416111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
    J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.
    Lun X; Yang W; Alain T; Shi ZQ; Muzik H; Barrett JW; McFadden G; Bell J; Hamilton MG; Senger DL; Forsyth PA
    Cancer Res; 2005 Nov; 65(21):9982-9990. PubMed ID: 16267023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates.
    Yang WQ; Lun X; Palmer CA; Wilcox ME; Muzik H; Shi ZQ; Dyck R; Coffey M; Thompson B; Hamilton M; Nishikawa SG; Brasher PM; Fonseca K; George D; Rewcastle NB; Johnston RN; Stewart D; Lee PW; Senger DL; Forsyth PA
    Clin Cancer Res; 2004 Dec; 10(24):8561-76. PubMed ID: 15623640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma.
    Yang WQ; Senger D; Muzik H; Shi ZQ; Johnson D; Brasher PM; Rewcastle NB; Hamilton M; Rutka J; Wolff J; Wetmore C; Curran T; Lee PW; Forsyth PA
    Cancer Res; 2003 Jun; 63(12):3162-72. PubMed ID: 12810644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic reovirus against ovarian and colon cancer.
    Hirasawa K; Nishikawa SG; Norman KL; Alain T; Kossakowska A; Lee PW
    Cancer Res; 2002 Mar; 62(6):1696-701. PubMed ID: 11912142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic.
    Thirukkumaran CM; Nodwell MJ; Hirasawa K; Shi ZQ; Diaz R; Luider J; Johnston RN; Forsyth PA; Magliocco AM; Lee P; Nishikawa S; Donnelly B; Coffey M; Trpkov K; Fonseca K; Spurrell J; Morris DG
    Cancer Res; 2010 Mar; 70(6):2435-44. PubMed ID: 20215509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir.
    Markert JM; Malick A; Coen DM; Martuza RL
    Neurosurgery; 1993 Apr; 32(4):597-603. PubMed ID: 8386343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.
    Fueyo J; Alemany R; Gomez-Manzano C; Fuller GN; Khan A; Conrad CA; Liu TJ; Jiang H; Lemoine MG; Suzuki K; Sawaya R; Curiel DT; Yung WK; Lang FF
    J Natl Cancer Inst; 2003 May; 95(9):652-60. PubMed ID: 12734316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
    Lun XQ; Jang JH; Tang N; Deng H; Head R; Bell JC; Stojdl DF; Nutt CL; Senger DL; Forsyth PA; McCart JA
    Clin Cancer Res; 2009 Apr; 15(8):2777-88. PubMed ID: 19351762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model.
    Kawaguchi K; Etoh T; Suzuki K; Mitui MT; Nishizono A; Shiraishi N; Kitano S
    Int J Oncol; 2010 Dec; 37(6):1433-8. PubMed ID: 21042711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All reovirus subtypes show oncolytic potential in primary cells of human high-grade glioma.
    Alloussi SH; Alkassar M; Urbschat S; Graf N; Gärtner B
    Oncol Rep; 2011 Sep; 26(3):645-9. PubMed ID: 21637921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer.
    Yang WQ; Senger DL; Lun XQ; Muzik H; Shi ZQ; Dyck RH; Norman K; Brasher PM; Rewcastle NB; George D; Stewart D; Lee PW; Forsyth PA
    Gene Ther; 2004 Nov; 11(21):1579-89. PubMed ID: 15372068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
    Galanis E; Bateman A; Johnson K; Diaz RM; James CD; Vile R; Russell SJ
    Hum Gene Ther; 2001 May; 12(7):811-21. PubMed ID: 11339897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.
    Geletneky K; Kiprianova I; Ayache A; Koch R; Herrero Y Calle M; Deleu L; Sommer C; Thomas N; Rommelaere J; Schlehofer JR
    Neuro Oncol; 2010 Aug; 12(8):804-14. PubMed ID: 20299703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.
    Kambara H; Okano H; Chiocca EA; Saeki Y
    Cancer Res; 2005 Apr; 65(7):2832-9. PubMed ID: 15805284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.
    Ogbomo H; Zemp FJ; Lun X; Zhang J; Stack D; Rahman MM; McFadden G; Mody CH; Forsyth PA
    PLoS One; 2013; 8(6):e66825. PubMed ID: 23762498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reovirus as a viable therapeutic option for the treatment of multiple myeloma.
    Thirukkumaran CM; Shi ZQ; Luider J; Kopciuk K; Gao H; Bahlis N; Neri P; Pho M; Stewart D; Mansoor A; Morris DG
    Clin Cancer Res; 2012 Sep; 18(18):4962-72. PubMed ID: 22761466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial passage through human glioma xenografts selects for a Deltagamma134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors.
    Shah AC; Price KH; Parker JN; Samuel SL; Meleth S; Cassady KA; Gillespie GY; Whitley RJ; Markert JM
    J Virol; 2006 Aug; 80(15):7308-15. PubMed ID: 16840311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.